All Those 23andMe Spit Tests Were Part of a Bigger Plan – Slashdot (Me: customers get some information but no share of the million$, billion$ that the firm may make off of their data…)

company is collaborating on clinical trials for one compound (and nearing trials for another) that could be used for what’s known as immuno-oncology, treatments that attempt to harness the body’s complex immune system to beat cancer. 23andMe says it’s also exploring drugs with potential use in treatments for neurological, cardiovascular, and other conditions, though it declined to specify them. Last month the company bought Lemonaid Health, a telehealth and drug delivery startup that offers treatment and prescriptions for a select group of conditions, including depression, anxiety, and STDs. Source: All Those 23andMe Spit Tests Were Part of a Bigger Plan – Slashdot